NewsBenzingaNeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M NeuroOne Medical Technologies Reports Preliminary Q4 Sales ~$3.8M , Up 38.4% YoY; Sees FY26 Sales Of ~$10.5M, Up 15.6% YoY; Includes September Purchase Order Of $4.5M Benzinga 2026.10.05 13:21 (GMT+0) Open on Benzinga Other news Anthropic Falls Over 8% in US Pre-Market Trading, Shares Now at $88.90 Tether's QVAC Reveals iPhone Offline Transcription Data: 96-Minute Movie in 28.7 Seconds Citi warns a key stock-market signal is close to flashing red Bank of America Boosts Strategy Stake, Total Holdings Rise to 1,865,500 Shares COMMENTARY: Morning Bid: AI’s last stand? Are Wall Street Analysts Bullish on Henry Schein Stock?